Return to program book search
Session Information
SYM S018
-
Cutting Edge Surgery & Oncology
Open admission, no tuition or ticket.
Subject:
Date:
Sunday, August 19
CME Credits:
3.00
Location:
Room 210
Time:
9:00 AM - 12:00 PM
Director:
Jeremy S. Bordeaux, MD, MPH, FAAD
Speakers:
- Murad Alam, MD, FAAD
- David R. Carr, MD, FAAD - Handout
- John A. Carucci, MD, PhD, FAAD
- Meg Gerstenblith, MD, FAAD
- Mary E. Maloney, MD, FAAD
- Christopher James Miller, MD, FAAD
- Joseph Sobanko, MD, FAAD
Learning Objectives:
Following this course, the attendee should be able to:
- Diagnose and treat skin cancer more effectively
- Differentiate and utilize newer techniques and therapies in surgical dermatology
Description:
The objective of this symposium is to update attendees on cutting edge topics in dermatology related to the diagnosis and treatment of skin cancer and surgical techniques. This session is directed to surgically oriented dermatologists.
Schedule:
| Sunday, August 19 |
|---|
| 9:00 AM | Introduction / Dr. Bordeaux |
| 9:05 AM | Bilayer Wound Matrix for Repair of Large, Complex Wounds on Exposed Bone / Dr. Maloney |
| 9:25 AM | Cutting Edge Techniques for the Treatment of Melanomas of the Head and Neck / Dr. Miller |
| 9:45 AM | Special Stains in Mohs Surgery / Dr. Sobanko |
| 10:05 AM | Multidisciplinary and Translational Approach to Aggressive Skin Cancers / Dr. Carucci |
| 10:25 AM | Questions / Dr. Maloney, Dr. Carr, Dr. Carucci, and Dr. Miller |
| 10:35 AM | Treatment of Primary Cutaneous Mucinous Carcinoma: Mohs vs. Excision / Dr. Alam |
| 10:55 AM | Two New Therapeutic Agents: Vemurafenib and Ingenol Mebutate / Dr. Carr |
| 11:15 AM | Cutaneous Side Effects of Vemurafenib: Keratoacanthomas and Beyond / Dr. Gerstenblith |
| 11:35 AM | Treatment of Primary Intranasal Basal Cell Carcinoma / Dr. Bordeaux |
| 11:50 AM | Questions / Dr. Bordeaux, Dr. Sobanko, Dr. Alam, and Dr. Gerstenblith |